According to a market report by Lucintel, the future of the global glucagon injectable market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global glucagon injectable market is expected to reach an estimated $1641.7 billion by 2030 from $1335.5 billion in 2024,at a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are rising prevalence of diabetes, increased awareness of hypoglycemia, and government initiatives aimed at improving diabetes management and access to essential medication.A more than 150-page report to understand trends, opportunity and forecast in glucagon injectable market to 2030 by age group (pediatrics and adults), route of administration (subcutaneous, intramuscular, and intravenous), application (therapeutic purpose and diagnostics purpose), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)
Lucintel forecasts that, within the application category, therapeutic purpose will remain the larger segment over the forecast period.
Within the distribution channel category, retail pharmacy is expected to witness the highest growth.
Download sample by clicking on glucagon injectable market
In terms of regions, North America will remain the largest region over the forecast period due to the presence of the major market player and increasing senior population.
Fresenius, Xeris Pharmaceuticals, Novo Nordisk, ILS, Amphastar Pharmaceuticals, Lilly, Avalon Pharmaare the major suppliers in the glucagon injectable market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Metal Air Battery Market
Methanol Market
Microprinting Market
Mine Ventilation System Market
Miniature Thermopile Detectors Market